Standard BioTools Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $94.6M | $28.5M |
| FY2022 | $64.9M | $-81.5M | $81.3M |
| FY2023 | $63.5M | $-148.1M | $51.7M |
| FY2024 | $299.0K | $471.7M | $166.7M |
| FY2025 | — | $424.3M | $120.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $94.6M | $28.5M |
| FY2022 | $64.9M | $-81.5M | $81.3M |
| FY2023 | $63.5M | $-148.1M | $51.7M |
| FY2024 | $299.0K | $471.7M | $166.7M |
| FY2025 | — | $424.3M | $120.9M |